Publications:

A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.

Nature Cancer

Gruber, Joshua J JJ; Afghahi, Anosheh A; Timms, Kirsten K; DeWees, Alyssa A; Gross, Wyatt W; Aushev, Vasily N VN; Wu, Hsin-Ta HT; Balcioglu, Mustafa M; Sethi, Himanshu H; Scott, Danika D; Foran, Jessica J; McMillan, Alex A; Ford, James M JM; Telli, Melinda L ML

Publication Date: 2022-10

Variant appearance in text: RARA: 746T>G; Phe249Cys

PubMed Link: 36253484

Variant Present in the following documents:

• 43018_2022_439_MOESM6_ESM.xlsx, sheet 1

View BVdb publication page